The European Commission has released Version 3 of its Living Guidelines on the Responsible Use of Generative AI in Research. Learn what the new recommendations mean for medical device manufacturers, clinical evaluation, data protection and research activities.

The recent completion of the FDA's artificial intelligence-supported pilot project marks an important step in the modernization of scientific review processes. With the promise of speeding up evaluations and reducing repetitive tasks, the FDA plans to implement generative AI across the board by June 2025.